Navigation Links
Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
Date:9/8/2008

d with excessive inflammation, including osteoarthritis and rheumatoid arthritis. For more information on Logical Therapeutics, visit the company's website at http://www.logicaltherapeutics.com or send an email to info@logicaltherapeutics.com


'/>"/>
SOURCE Logical Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 1Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 2Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 3Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 4Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 5Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 6Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 7Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 8Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 9Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 10Reportlinker Adds Worldwide Optical Transmission TEM and Scanning SEM Electron Microscope Market Shares Strategies and Forecasts 2009 to 2015 14647 11Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 1Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 2Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2